Jagsonpal Pharmaceuticals Share Price

Jagsonpal Pharmaceuticals Share Price

NSE: JAGSNPHARM
|
Pharmaceuticals
|
S Cap
₹ 242.93
+₹5.90 (2.49%)
1D
Last updated 03 Sep, 2026, 14:00 IST

Jagsonpal Pharmaceuticals Share Price Today

As of 3 Sep 2026, Jagsonpal Pharmaceuticals share price is ₹242.93. The stock opened at ₹237.40, compared to its previous close of ₹237.03. During today's trading session, Jagsonpal Pharmaceuticals share price moved in the range of ₹237.01 to ₹249.57, with an average price of ₹243.29 for the day. Looking at its last 52-week, the stock has touched a low of ₹155.00 and a high of ₹264.50. On the performance front, Jagsonpal Pharmaceuticals share price has increased by 44.05% over the last six months and is down 2.02% on a year-on-year basis.

₹237.01
2.49% up today
₹249.57
1D LOW
1D HIGH

Jagsonpal Pharmaceuticals Returns Calculator

Circuit
L
H
₹189.63
₹284.43
52-week
L
H
₹155.00
₹264.50

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals Share Price
ISIN
INE048B01035
Sector Market Cap
₹ 1,563.52 Cr

Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Jagsonpal Pharmaceuticals Financial Highlights

  • Revenue: Jagsonpal Pharmaceuticals reported revenue of ₹299.23 crore in FY26 vs ₹276.91 crore in FY25. It showed an increase of 8.06% on a yearly basis.
  • Operating Profit: Jagsonpal Pharmaceuticals reported an operating profit of ₹57.52 crore in FY26 vs ₹69.86 crore in FY25. It showed a decrease of 17.66% on a year-on-year basis.
  • Net Profit: Jagsonpal Pharmaceuticals reported a net profit of ₹43.08 crore in FY26 vs ₹55.36 crore in FY25. It showed a decrease of 22.18% on a yearly basis.

Jagsonpal Pharmaceuticals Quarterly Result Highlights

  • Jagsonpal Pharmaceuticals reported revenue of ₹85.06 crore in Jun 2026, compared with ₹67.37 crore in Mar 2026, representing an increase of 26.26% on a quarter-on-quarter (QoQ) basis.
  • Jagsonpal Pharmaceuticals reported an operating profit of ₹17.68 crore in Jun 2026, compared with ₹11.76 crore in Mar 2026, representing an increase of 50.34% on a quarter-on-quarter (QoQ) basis.
  • Jagsonpal Pharmaceuticals reported a profit of ₹13.19 crore in Jun 2026, compared with ₹8.76 crore in Mar 2026, reflecting an increase of 50.57% on a QoQ basis.
  • The earnings per share (EPS) of Jagsonpal Pharmaceuticals stood at ₹8.26 during Jun 2026.
Know more
Promoters
69.05%
FII
2.30%
Other DII
0.62%
Retail and other
28.03%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20252.12%
Dec 20252.12%
Mar 20262.44%
Jun 20262.30%
Mkt Cap Cr
1,563.52
P/E
34.40
P/B
5.67
ROE
15.60%
D/E
0.03
ROCE
20.59%
Div. Yield
1.71%
EPS(TTM)
6.40
Turnover
0.93
EV/EBITDA
20.88
Net Margin
0.00%
Op. Margin
0.00%
ROA
14.36%
Quick Ratio
0.00
Curr. Ratio
5.35
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Jagsonpal Pharma outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Jagsonpal Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Jagsonpal Pharmaceuticals Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹268.72₹208.70₹236.71₹217.58
Other Income₹8.19₹9.28₹5.73₹3.43
Total Revenue₹276.91₹217.98₹242.45₹221.01
Total Expenses₹226.73₹188.11₹204.18₹194.37
Profit Before Tax₹69.86₹29.87₹34.81₹26.64
Tax₹14.50₹7.41₹8.09₹7.79
Profit After Tax₹55.36₹22.46₹26.72₹18.86
EPS - Basic₹8.26₹3.40₹10.20₹7.20
EPS - Diluted₹8.22₹3.39₹10.20₹7.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹69.86₹29.87₹34.81₹26.64
Income before WC changes₹57.92₹38.14₹44.44₹25.24
Change in Assets-₹1.48₹11.12₹9.39-₹8.62
Change in Liabilities₹7.00-₹5.58₹0.10-₹2.84
Change in WC₹5.52₹5.54₹9.50-₹11.46
Cash flow from Operations₹55.30₹35.17₹46.66₹6.91
Cash flow from Investing-₹45.15-₹24.55-₹57.67-₹25.78
Cash flow from Financing-₹11.70-₹8.91-₹0.46-₹17.55
Total Cash Flow-₹1.55₹1.71-₹11.47-₹36.42
Cash (Start of the year)₹12.76₹11.05₹22.53₹58.94
Cash (End of the year)₹11.22₹12.76₹11.05₹22.53

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹117.07₹20.30₹30.39₹55.14
Current Assets₹161.19₹196.78₹164.56₹109.08
Total Assets₹278.26₹217.08₹194.95₹164.23
Current Liabilities₹25.90₹19.13₹27.57₹26.97
Net Current Asset₹135.29₹177.65₹136.99₹82.11
Non-Current Liabilities₹12.41₹10.55₹8.49₹4.49
Equity Capital₹239.95₹187.40₹158.89₹132.76
Total Equity & Liabilities₹278.26₹217.08₹194.95₹164.23
* All values are in INR Crore
Qty
Bid
3
242.44
9
242.41
10
242.28
3
242.27
3
242.26
Ask
Qty
242.88
1
242.93
10
242.94
19
242.95
97
242.99
1
Bid Total: 28
Ask Total: 128
Buy orders: 18%
Sell orders: 82%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.46
Neutral
ATR (14)
7.71
Neutral
STOCH(9,6)
27.83
Neutral
STOCH RSI (14)
41.25
Neutral
ADX(9)
38.33
Bearish
UO(9)
40.73
Neutral
ROC(12)
1.5
Bullish
WillR(14)
-46.94
Neutral
Period
Simple value
Exponential vaue
5D
238.71
238.64
10D
238.75
237.85
20D
234.87
235.72
50D
231.92
229.62
100D
218.79
220.23
Volume trend — traded volume by day
3 Sep2L
2 Sep0L
1 Sep0L
31 Aug2L
28 Aug0L
27 Aug0L
Average1L
Compare against other stocks
Jagsonpal Pharmaceuticals Share Price
Jagsonpal Pharmaceuticals
Pharmaceuticals
Add Stock
Add Another

Jagsonpal Pharmaceuticals Share Price FAQs